Table 4.
Clinical diagnosis | Sequencing performed number of patients | Positive results number of patients | Diagnostic yield percent |
---|---|---|---|
Alport syndrome | 206 | 127 | 61.7 |
Tubular disease | 134 | 74 | 55.2 |
Cystic kidney disease | 506 | 256 | 50.6 |
Glomerular disease | 50 | 19 | 38.0 |
Other | 122 | 45 | 36.9 |
Complement-mediated | 89 | 26 | 29.2 |
Nephrotic disease | 142 | 41 | 28.9 |
CAKUT | 73 | 18 | 24.7 |
Totala | 1322 | 606 | 45.8 |
CAKUT, congenital anomalies of the kidney and urinary tract-syndromic; DY, diagnostic yield (was calculated using the formula: DY = (PR / [PR + NR + VUS] × 100) and is expressed in percent (%); NR, negative result; PR, positive result; VUS, a variant of unknown significance.
Test results were unknown for 59 patients by the end of the 2022 cut-off.